Critical Value Reporting in Transfusion Medicine A Survey of Communication Practices in US Facilities

被引:1
作者
Reese, Erika M. [1 ,2 ]
Nelson, Randin C. [1 ,3 ]
Flegel, Willy A. [1 ]
Byrne, Karen M. [1 ]
Booth, Garrett S. [4 ]
机构
[1] NIH, Dept Transfus Med, Ctr Clin, 10 Ctr Dr,MSC 1184,Rm 1C711, Bethesda, MD 20892 USA
[2] Univ Maryland, Med Ctr, Labs Pathol, Baltimore, MD 21201 USA
[3] Staten Isl Univ Hosp, Dept Pathol, Staten Isl, NY USA
[4] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA
基金
美国国家卫生研究院;
关键词
Critical values; Blood bank; Communication; Results; Transfusion; PATHOLOGISTS Q-PROBES; CRITICAL LIMITS; NOTIFICATION; REDUCTION; POLICIES; ERROR;
D O I
10.1093/AJCP/AQX025
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objectives: While critical value procedures have been adopted in most areas of the clinical laboratory, their use in transfusion medicine has not been reviewed in detail. The results of this study present a comprehensive overview of critical value reporting and communication practices in transfusion medicine in the United States. Methods: A web-based survey was developed to collect data on the prevalence of critical value procedures and practices of communicating results. The survey was distributed via email to US hospital-based blood banks. Results: Of 123 facilities surveyed, 84 (68.3%) blood banks had a critical value procedure. From a panel of 23 common blood bank results, nine results were selected by more than 70% of facilities as either a critical value or requiring rapid communication as defined by an alternate procedure. Conclusions: There was overlap among results communicated by facilities with and without a critical value procedure. The most frequently communicated results, such as incompatible crossmatch for RBC units issued uncrossmatched, delay in finding compatible blood due to a clinically significant antibody, and transfusion reaction evaluation suggestive of a serious adverse event, addressed scenarios associated with the leading reported causes of transfusion-related fatalities.
引用
收藏
页码:492 / 499
页数:8
相关论文
共 31 条
[1]  
[Anonymous], LAB ACCR PROGR ALL C
[2]  
[Anonymous], LAB ACCR PROGR TRANS
[3]  
[Anonymous], NAT PAT SAF GOALS LA
[4]   Improving patient safety by repeating (read-back) telephone reports of critical information [J].
Barenfanger, J ;
Sautter, RL ;
Lang, DL ;
Collins, SM ;
Hacek, DM ;
Peterson, LR .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004, 121 (06) :801-803
[5]  
Dighe AS, 2008, ARCH PATHOL LAB MED, V132, P1666, DOI 10.1043/1543-2165(2008)132[1666:SOCVRA]2.0.CO
[6]  
2
[7]   Laboratory defined critical value limits: How do hospital physicians perceive laboratory based critical values? [J].
Don-Wauchope, Andrew C. ;
Chetty, Vasudhevan T. .
CLINICAL BIOCHEMISTRY, 2009, 42 (09) :766-770
[8]  
Emancipator K, 1997, AM J CLIN PATHOL, V108, P247
[9]  
FDA, Fatalities Reported to FDA Following Blood Collection and Transfusion Annual Summary for FY2018 2018
[10]  
Fung MK., 2014, AABB TECHNICAL MANUA